awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38202556-5ECEE39B-6FCE-4EEA-8FC2-476C485071F0
Q38202556-5ECEE39B-6FCE-4EEA-8FC2-476C485071F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38202556-5ECEE39B-6FCE-4EEA-8FC2-476C485071F0
STAT3 inhibitors: finding a home in lymphoma and leukemia.
P2860
Q38202556-5ECEE39B-6FCE-4EEA-8FC2-476C485071F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38202556-5ECEE39B-6FCE-4EEA-8FC2-476C485071F0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9066b32ea77a4ddff98535f1024d693fa1335c2f
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.